Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Feb 3:14:e4.
doi: 10.1017/S1462399411002110.

Molecular mechanisms underlying chemical liver injury

Affiliations
Review

Molecular mechanisms underlying chemical liver injury

Xinsheng Gu et al. Expert Rev Mol Med. .

Abstract

The liver is necessary for survival. Its strategic localisation, blood flow and prominent role in the metabolism of xenobiotics render this organ particularly susceptible to injury by chemicals to which we are ubiquitously exposed. The pathogenesis of most chemical-induced liver injuries is initiated by the metabolic conversion of chemicals into reactive intermediate species, such as electrophilic compounds or free radicals, which can potentially alter the structure and function of cellular macromolecules. Many reactive intermediate species can produce oxidative stress, which can be equally detrimental to the cell. When protective defences are overwhelmed by excess toxicant insult, the effects of reactive intermediate species lead to deregulation of cell signalling pathways and dysfunction of biomolecules, leading to failure of target organelles and eventual cell death. A myriad of genetic factors determine the susceptibility of specific individuals to chemical-induced liver injury. Environmental factors, lifestyle choices and pre-existing pathological conditions also have roles in the pathogenesis of chemical liver injury. Research aimed at elucidating the molecular mechanism of the pathogenesis of chemical-induced liver diseases is fundamental for preventing or devising new modalities of treatment for liver injury by chemicals.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Generation of excess reactive chemical species leads to molecular damage in hepatocytes
Reactive species (pink boxes) are generated during biotransformation of toxicophores, which can then be detoxified by drug-metabolising enzymes and antioxidant systems (green boxes). Excess reactive chemical species react with biomolecules to form molecular adducts, peroxides or broken molecular fragments (purple box), resulting in dysfunction or change in the structure of biomolecules. Green arrows indicate detoxification pathways; red arrows show toxification pathways. CAT, catalase; GSH, glutathione; GPX, glutathione peroxidase; GST, glutathione S-transferase; NOS, nitric oxide synthase; NQO1, NAD(P)H quinone oxidoreductase 1; Prx, peroxiredoxin; SOD, superoxide dismutase; SULT, sulfotransferase; UGT, glucuronosyltransferase. Parts of this figure are adapted from portions of figures from Refs , .
Figure 2
Figure 2. Liver cell death occurs when the integrity of cellular organelles is impaired by oxidative stress and damage to biomolecules
Damage to biomolecules and oxidative stress can be reversed or tolerated by activation of compensatory responses. Excessive damage or modification of biomolecules by oxidative stress can overwhelm the capacity of repair and adaptive processes, leading to uncorrected changes to critical organelles, among which mitochondria is the most important. This can lead to activation of immune responses, which could further aggravate cellular damage. The interplay between xenobiotic-induced molecular changes, organelle dysfunction and activation of immunity results in cell death and liver injury. Cellular ATP availability is an important determinant of the type of cell death that occurs. Programmed cell death or apoptosis requires ATP, whereas oncotic death (necrosis) predominates when ATP stores are depleted. However, massive apoptosis also leads to apoptotic necrosis. Green boxes indicate normal homeostasis; boxes of other colours show events leading to liver cell injury. Green arrows indicate pathways leading to cell recovery; red arrows show pathways leading to cell damage or death.
Figure 3
Figure 3. The pathogenesis of chemical liver injury is controlled by genetic, environmental, patho-physiological and dietary factors
Other factors such as gender, race, age and lifestyle choices can be risk factors for certain forms of chemical liver injury. The interplay between these factors controls gene transcription and cell signalling events, leading to a myriad of interconnected outcomes such as imbalances between detoxification and toxification metabolic pathways, impaired organelle function, compromised ability to repair molecular damage and alterations in overall cellular homeostasis. With prominent shifts in normal cellular homeostasis, the ability of compensatory and adaptive responses to correct the detrimental effects of toxicants can be hampered. Similarly, repair mechanisms can be overwhelmed and incapable of correcting the cellular chemical injury. Green arrows indicate pathways leading to cell recovery; red arrows show pathways to cell damage or death; black arrows indicate pathways that contribute to chemical-induced liver injury.

Similar articles

Cited by

References

    1. Nemeth E, Baird AW, O’Farrelly C. Microanatomy of the liver immune system. Seminars in Immunopathology. 2009;31:333–343. - PubMed
    1. Dienes HP, Drebber U. Pathology of immune-mediated liver injury. Digestive Diseases. 2010;28:57–62. - PubMed
    1. Misdraji J. Embryology, anatomy, histology, and developmental anomalies of the liver. In: Sleisenger MH, Feldman M, et al., editors. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 9. Saunders/Elsevier; Philadelphia, PA: 2010. pp. 1201–1206.
    1. Carithers RL, Jr, Mcclain CJ. Alcoholic liver disease. In: Sleisenger MH, Feldman M, et al., editors. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 9. Saunders/Elsevier; Philadelphia, PA: 2010. pp. 1383–1400.
    1. Jungermann K, Kietzmann T. Zonation of parenchymal and nonparenchymal metabolism in liver. Annual Review of Nutrition. 1996;16:179–203. - PubMed

Further reading, resources and contacts

    1. Gregus Z. Mechanism of toxicity. In: Casarett LJ, Doull J, et al., editors. Casarett and Doull’s Toxicology: The Basic Science of Poisons. 7. McGraw-Hill; New York: 2008. pp. 45–106. This book chapter provides the most comprehensive and detailed information on the molecular and cellular mechanism of toxicity by xenobiotics.
    1. Kaplowitz N. Biochemical and cellular mechanisms of toxic liver injury. Seminars in Liver Disease. 2002;22:137–144. This review focuses on the mechanisms of different forms of cell death. - PubMed
    1. Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Safety. 2007;30:277–294. This review provides practical information on the diagnosis and management of patients with suspected drug-related liver disease. Pathogenesis is also discussed briefly. - PubMed
    1. Testa B, Kramer SD. The biochemistry of drug metabolism – an introduction: parts 2–5. Redox, hydrolysis, conjugation reactions and their enzymes, metabolism and bioactivity. Chemistry and Biodiversity. 2007–2009;4456:257–405. 2031–2122, 2171–2336, 591–684. - PubMed
    1. Parkinson A, Ogilvie BW. Biotransformation of xenobiotics. In: Casarett LJ, Doull J, et al., editors. Casarett and Doull’s Toxicology: The Basic Science of Poisons. 7. McGraw-Hill; New York: 2008. pp. 161–304. The reviews by Test and Kramer and the book chapter by Parkinson and Ogilvie demonstrate comprehensive and detailed information on detoxification and bio-activation of xenobiotics.

Publication types

MeSH terms